137 related articles for article (PubMed ID: 25160935)
1. Effect of CD4+ cell count and viral suppression on risk of ischemic stroke in HIV infection.
Chow FC; Bacchetti P; Kim AS; Price RW; Hsue PY
AIDS; 2014 Nov; 28(17):2573-7. PubMed ID: 25160935
[TBL] [Abstract][Full Text] [Related]
2. HIV infection and incidence of ischemic stroke.
Marcus JL; Leyden WA; Chao CR; Chow FC; Horberg MA; Hurley LB; Klein DB; Quesenberry CP; Towner WJ; Silverberg MJ
AIDS; 2014 Aug; 28(13):1911-9. PubMed ID: 24937309
[TBL] [Abstract][Full Text] [Related]
3. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
[TBL] [Abstract][Full Text] [Related]
4. Immunologic function and virologic suppression among children with perinatally acquired HIV Infection on highly active antiretroviral therapy.
Rutstein RM; Gebo KA; Flynn PM; Fleishman JA; Sharp VL; Siberry GK; Spector SA
Med Care; 2005 Sep; 43(9 Suppl):III15-22. PubMed ID: 16116305
[TBL] [Abstract][Full Text] [Related]
5. HIV replication and immune status are independent predictors of the risk of myocardial infarction in HIV-infected individuals.
Lang S; Mary-Krause M; Simon A; Partisani M; Gilquin J; Cotte L; Boccara F; Costagliola D;
Clin Infect Dis; 2012 Aug; 55(4):600-7. PubMed ID: 22610928
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era.
D'Ascenzo F; Quadri G; Cerrato E; Calcagno A; Omedè P; Grosso Marra W; Abbate A; Bonora S; Biondi Zoccai G; Moretti C; Gaita F
J Cardiovasc Med (Hagerstown); 2015 Dec; 16(12):839-43. PubMed ID: 24979113
[TBL] [Abstract][Full Text] [Related]
7. Association of CD4+ T-cell Count, HIV-1 RNA Viral Load, and Antiretroviral Therapy With Kaposi Sarcoma Risk Among HIV-infected Persons in the United States and Canada.
Dubrow R; Qin L; Lin H; Hernández-Ramírez RU; Neugebauer RS; Leyden W; Althoff KN; Achenbach CJ; Hessol NA; Modur SP; DʼSouza G; Bosch RJ; Grover S; Horberg MA; Kitahata MM; Mayor AM; Novak RM; Rabkin CS; Sterling TR; Goedert JJ; Justice AC; Engels EA; Moore RD; Silverberg MJ;
J Acquir Immune Defic Syndr; 2017 Aug; 75(4):382-390. PubMed ID: 28394855
[TBL] [Abstract][Full Text] [Related]
8. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for pediatric human immunodeficiency virus-related malignancy.
Pollock BH; Jenson HB; Leach CT; McClain KL; Hutchison RE; Garzarella L; Joshi VV; Parmley RT; Murphy SB
JAMA; 2003 May; 289(18):2393-9. PubMed ID: 12746363
[TBL] [Abstract][Full Text] [Related]
10. Greater Risk of Stroke of Undetermined Etiology in a Contemporary HIV-Infected Cohort Compared with Uninfected Individuals.
Chow FC; Price RW; Hsue PY; Kim AS
J Stroke Cerebrovasc Dis; 2017 May; 26(5):1154-1160. PubMed ID: 28262563
[TBL] [Abstract][Full Text] [Related]
11. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
[TBL] [Abstract][Full Text] [Related]
12. CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.
Torti C; Lapadula G; Barreiro P; Soriano V; Mandalia S; De Silvestri A; Suter F; Maggiolo F; Antinori A; Antonucci F; Maserati R; El Hamad I; Pierotti P; Sighinolfi L; Migliorino G; Ladisa N; Carosi G;
J Antimicrob Chemother; 2007 Jun; 59(6):1141-7. PubMed ID: 17434879
[TBL] [Abstract][Full Text] [Related]
13. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
[TBL] [Abstract][Full Text] [Related]
14. Retinal microangiopathy in human immunodeficiency virus infection is related to higher human immunodeficiency virus-1 load in plasma.
Furrer H; Barloggio A; Egger M; Garweg JG;
Ophthalmology; 2003 Feb; 110(2):432-6. PubMed ID: 12578793
[TBL] [Abstract][Full Text] [Related]
15. Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapy.
Staszewski S; Miller V; Sabin C; Schlecht C; Gute P; Stamm S; Leder T; Berger A; Weidemann E; Hill A; Phillips A
AIDS; 1999 May; 13(8):951-6. PubMed ID: 10371176
[TBL] [Abstract][Full Text] [Related]
16. Retention in care is more strongly associated with viral suppression in HIV-infected patients with lower versus higher CD4 counts.
Yehia BR; French B; Fleishman JA; Metlay JP; Berry SA; Korthuis PT; Agwu AL; Gebo KA;
J Acquir Immune Defic Syndr; 2014 Mar; 65(3):333-9. PubMed ID: 24129370
[TBL] [Abstract][Full Text] [Related]
17. Genotypic susceptibility score (GSS) and CD4+ T cell recovery in HIV-1 patients with suppressed viral load.
Gonzalez-Serna A; Glas AC; Brumme CJ; Poon AF; Nohpal De La Rosa A; Mudrikova T; Dias Lima V; Wensing AM; Harrigan R
J Antimicrob Chemother; 2017 Feb; 72(2):496-503. PubMed ID: 27999069
[TBL] [Abstract][Full Text] [Related]
18. Optimization of human immunodeficiency virus treatment during incarceration: viral suppression at the prison gate.
Meyer JP; Cepeda J; Wu J; Trestman RL; Altice FL; Springer SA
JAMA Intern Med; 2014 May; 174(5):721-9. PubMed ID: 24687044
[TBL] [Abstract][Full Text] [Related]
19. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
[TBL] [Abstract][Full Text] [Related]
20. Ischaemic stroke in HIV-infected patients: a case-control study.
Silva-Pinto A; Costa A; Serrão R; Sarmento A; Abreu P
HIV Med; 2017 Mar; 18(3):214-219. PubMed ID: 27535019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
